Selected Documents and Publications

 

• “Tele-ICU And Clinical Quality,” Letter to the Editor, Health Affairs, November/December 2009, pp 1858-59

• “Electronic Medical Records: Setting the Records Straight,” Medical Times of the Middle East, June 2008

• Tele-ICUs: Interim Findings about Remote Monitoring and Management of Patients in Intensive Care Units: A FAST Initiative Technology Analysis, Discussion Draft for the New England Healthcare Institute, Prepared by Michael D. Miller, MD & Sheila Fifer, PhD – August 2006

• A White Paper Analysis of Marcia Angell’s February 12, 2007 Boston Globe Column, “High cost of me-too drugs”

• “Implications of pharmaceutical ballot propositions for veterans,” California Legionnaire, Sept/Oct 2005.

• “Life sciences companies can expect lively drug pricing debate in 2005,” Mass High Tech, Life Science Strategies Supplement, January 17, 2005 [link to Mass High Tech]

• VA Pharmaceutical Price Controls, Rationing, and Medicare,” January 2005 (Summary)

• “Drug Pricing Principles” in “The Entrepreneur’s Guide to a Biotech Startup,” 4th Edition, May 2004

• “New Advancements in Treating Osteoporosis” July 2003 (Unpublished Article)

• “The Pharmaceutical Industry’s Contribution to Economic Development and Prosperity in Pennsylvania,” Testimony Before House Majority Policy Committee Hearing, Sub-Committee on Prescription Drugs (PACE/PACENET), Folsom, PA, July 16, 2002

• Testimony Before the United States Senate’s Committee on Veterans’ Affairs, Hearing on Prescription Drug Issues in the Department of Veterans Affairs, July 24, 2001

• “Working Together on Common Concerns and Complex Solutions,” PhRMA’s “Patient Matters” Newsletter, Fall 2000

• Congressional Testimony in support of funding for NHGRI and NIH on behalf of The Genome Action Coalition (with Vicky Wittemore, Ph.D. National Tuberous Sclerosis Association), House Appropriations Labor-HHS Subcommittee, 13 April, 1999

• Congressional Testimony in support of funding for the NIH on behalf of FDA-NIH Council, House Appropriations Labor-HHS Subcommittee, 28 January, 1998

• The Value of Prescription Drugs and Pharmaceutical Research, Pfizer Briefing Book, Editor, 1995, 1996, 1997 Editions

• Miller, M.D., Remillard, S., “Preparing for Managed Care and Capitation,” in, Alliances:  Strategies for Building Integrated Delivery Systems, Aspen Publications, 1995

• Patent # 4,857,061: “Single-Flow Valve-Hypodermic Needle Combination,” 15 August, 1989

• Puzas, J.E., Miller, M.D., Rosier, R.N., “Pathological Bone Formation,” Clinical Orthopaedics and Related Research 245, pp 269-281, 1989

• Miller, M.D., Hausman, M., Jokl, P., Lindsey, R.W., “Permanent Post-Traumatic Patellar Dislocation, Journal of Trauma, 24(9) pp 1389-92, 1988

• Miller, M.D. “Retrospective Study of Pelvic Fractures at the Medical Center Hospital of Vermont,” unpublished study, 1987

• Markgraf, J.H., Bums, D.B., Greeno, E.W., Leonard, K.J., Miller, M.D., “The Dehydration of Allylic and Benzylic Cycloalkanoids by Molecular Sieves,” Synthetic Communications, 14(7), pp 647-653, 1984